Evolent Health EBITDA Margin 2014-2025 | EVH
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Evolent Health (EVH) over the last 10 years. The current EBITDA margin for Evolent Health as of June 30, 2025 is .
| Evolent Health EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| 2025-06-30 | $2.20B | $0.08B | 3.60% |
| 2025-03-31 | $2.40B | $0.09B | 3.92% |
| 2024-12-31 | $2.56B | $0.09B | 3.41% |
| 2024-09-30 | $2.46B | $0.09B | 3.49% |
| 2024-06-30 | $2.35B | $0.09B | 3.74% |
| 2024-03-31 | $2.18B | $0.06B | 2.90% |
| 2023-12-31 | $1.96B | $0.07B | 3.41% |
| 2023-09-30 | $1.79B | $0.08B | 4.58% |
| 2023-06-30 | $1.63B | $0.10B | 5.88% |
| 2023-03-31 | $1.48B | $0.09B | 6.34% |
| 2022-12-31 | $1.35B | $0.10B | 7.17% |
| 2022-09-30 | $1.22B | $0.08B | 6.57% |
| 2022-06-30 | $1.09B | $0.06B | 5.70% |
| 2022-03-31 | $0.99B | $0.07B | 6.67% |
| 2021-12-31 | $0.91B | $0.05B | 5.29% |
| 2021-09-30 | $0.91B | $0.07B | 7.40% |
| 2021-06-30 | $0.92B | $0.06B | 6.60% |
| 2021-03-31 | $0.92B | $0.06B | 6.20% |
| 2020-12-31 | $0.93B | $0.05B | 5.41% |
| 2020-09-30 | $0.76B | $0.02B | 3.18% |
| 2020-06-30 | $0.74B | $0.02B | 2.04% |
| 2020-03-31 | $0.71B | $0.00B | -0.56% |
| 2019-12-31 | $0.69B | $-0.03B | -4.80% |
| 2019-09-30 | $0.80B | $-0.03B | -3.99% |
| 2019-06-30 | $0.73B | $-0.03B | -4.23% |
| 2019-03-31 | $0.69B | $-0.02B | -3.36% |
| 2018-12-31 | $0.63B | $0.00B | 0.32% |
| 2018-09-30 | $0.55B | $-0.01B | -1.64% |
| 2018-06-30 | $0.51B | $-0.02B | -2.96% |
| 2018-03-31 | $0.47B | $-0.03B | -6.18% |
| 2017-12-31 | $0.44B | $-0.04B | -9.20% |
| 2017-09-30 | $0.41B | $-0.06B | -14.67% |
| 2017-06-30 | $0.36B | $-0.07B | -18.28% |
| 2017-03-31 | $0.31B | $-0.06B | -20.26% |
| 2016-12-31 | $0.25B | $-0.06B | -23.23% |
| 2016-09-30 | $0.21B | $-0.04B | -20.28% |
| 2016-06-30 | $0.19B | $-0.05B | -23.44% |
| 2016-03-31 | $0.15B | $-0.05B | -33.10% |
| 2015-09-30 | $0.03B | $-0.01B | -46.67% |
| 2014-12-31 | $0.00B | $0.00B | 0.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $1.089B | $2.555B |
| Evolent Health, Inc. is involved in the healthcare delivery and payment markets. The company provides technology-enabled services platform for providers to transition their organization in value-based payment models. Evolent Health, Inc. is based in Arlington, Virginia. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $46.824B | 59.57 |
| Tempus AI (TEM) | United States | $13.255B | 0.00 |
| Doximity (DOCS) | United States | $12.564B | 55.90 |
| Hims & Hers Health (HIMS) | United States | $10.250B | 83.98 |
| IRhythm Technologies (IRTC) | United States | $5.398B | 0.00 |
| Hinge Health (HNGE) | United States | $4.325B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $2.713B | 39.89 |
| Privia Health (PRVA) | United States | $2.625B | 194.46 |
| Heartflow (HTFL) | $2.547B | 0.00 | |
| Phreesia (PHR) | United States | $1.833B | 0.00 |
| Enovis (ENOV) | United States | $1.782B | 9.42 |
| 10x Genomics (TXG) | United States | $1.747B | 0.00 |
| Omnicell (OMCL) | United States | $1.503B | 28.96 |
| Schrodinger (SDGR) | United States | $1.446B | 0.00 |
| Azenta (AZTA) | United States | $1.401B | 61.14 |
| Clover Health Investments (CLOV) | United States | $1.368B | 0.00 |
| Claritev (CTEV) | United States | $1.196B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.657B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.585B | 0.00 |
| Veradigm (MDRX) | United States | $0.536B | 0.00 |
| Standard BioTools (LAB) | United States | $0.493B | 0.00 |
| Talkspace (TALK) | United States | $0.447B | 133.50 |
| Butterfly Network (BFLY) | United States | $0.400B | 0.00 |
| Carlsmed (CARL) | United States | $0.365B | 0.00 |
| TruBridge (TBRG) | United States | $0.300B | 52.66 |
| Outset Medical (OM) | United States | $0.251B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.246B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.228B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.218B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.197B | 0.00 |
| CapsoVision (CV) | United States | $0.184B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.171B | 0.00 |
| CareCloud (CCLD) | United States | $0.156B | 7.08 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.127B | 0.00 |
| American Well (AMWL) | United States | $0.113B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.084B | 0.00 |
| Pulmonx (LUNG) | United States | $0.072B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.072B | 0.00 |
| 111 (YI) | China | $0.061B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.057B | 0.00 |
| HeartBeam (BEAT) | United States | $0.039B | 0.00 |
| Zhongchao (ZCMD) | China | $0.025B | 0.00 |
| Precipio (PRPO) | United States | $0.023B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.016B | 0.00 |
| PROFUSA (PFSA) | United States | $0.014B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.013B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.010B | 0.00 |
| HeartSciences (HSCS) | United States | $0.008B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.007B | 0.00 |
| Movano (MOVE) | United States | $0.005B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.005B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.004B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |